US EditionPublished • loading... • Updated
FDA Grants Protaryx Medical Clearance for Transseptal Puncture Device
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Protaryx Medical receives US FDA clearance for proprietary transseptal puncture device
Protaryx Protaryx Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its proprietary transseptal puncture device. According to the company, the milestone represents a significant advancement in its mission to redefine safe, efficient, and reproducible left heart access for cardiac interventions, enabling broader adoption and improved delivery of minimally invasive therapies. The device is a novel cathe…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
